Regenxbio
Price & Volume
Stats
See more52W Range | $5.03-$13.92 |
Market Cap | $671.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $161.3M |
Revenue Growth (YoY) | 22.9% |
Gross Profit (12 Mos) | -$78.4M |
Diluted EPS | -$3.46 |
News
See moreYahoo Finance • 2 days ago
Regenxbio files $300M mixed shelf offering
Yahoo Finance • 23 days ago
REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights
Yahoo Finance • 2 months ago
REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting
Yahoo Finance • 2 months ago
Advanced Viral Delivery Systems Revolutionizing Gene Therapy for Neurological Disorders
About
CEO | Mr. Curran M. Simpson M.S. |
CFO | Mr. Mitchell Chan M.B.A. |
Address | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 353 |
